The life sciences and pharmaceutical sectors suffer from hard-to-source biological materials, which translates into high costs in research and development
Researchers have developed a plasma-based disinfectant generated with the help of cold atmospheric pressure plasma (CAP) which could act as a green decontaminant for Covid-19
The purpose of the study is to investigate safety and tolerability of SNIPR001 in healthy volunteers and to evaluate the effect of SNIPR001 on reducing E. coli colonization in the gut
Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company's global growth journey
By strengthening the company's fibrotic disease development pipeline, Bridge will enhance its strategic focus on the development of comprehensive treatment solutions for idiopathic pulmonary fibrosis (IPF)
New product line to address the challenge of restrictions on use of plastic straws
The data driven fertility company helps increase the success rate of fertility treatments
Jamnagar’s contributions towards wellness will get a global identity with WHO’s Global Centre for Traditional Medicine
The HD-550 endoscopy system has been available outside of the USA since 2019
Marks the second of three biosimilars Amneal expects to receive U.S. approval for in 2022
Subscribe To Our Newsletter & Stay Updated
